These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 15007382)

  • 1. Integration of high-resolution array comparative genomic hybridization analysis of chromosome 16q with expression array data refines common regions of loss at 16q23-qter and identifies underlying candidate tumor suppressor genes in prostate cancer.
    Watson JE; Doggett NA; Albertson DG; Andaya A; Chinnaiyan A; van Dekken H; Ginzinger D; Haqq C; James K; Kamkar S; Kowbel D; Pinkel D; Schmitt L; Simko JP; Volik S; Weinberg VK; Paris PL; Collins C
    Oncogene; 2004 Apr; 23(19):3487-94. PubMed ID: 15007382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-resolution array comparative genomic hybridization of chromosome arm 8q: evaluation of genetic progression markers for prostate cancer.
    van Duin M; van Marion R; Vissers K; Watson JE; van Weerden WM; Schröder FH; Hop WC; van der Kwast TH; Collins C; van Dekken H
    Genes Chromosomes Cancer; 2005 Dec; 44(4):438-49. PubMed ID: 16130124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular analysis of WFDC1/ps20 gene in prostate cancer.
    Watson JE; Kamkar S; James K; Kowbel D; Andaya A; Paris PL; Simko J; Carroll P; McAlhany S; Rowley D; Collins C
    Prostate; 2004 Oct; 61(2):192-9. PubMed ID: 15305342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of a small region around the PTEN locus is a major chromosome 10 alteration in prostate cancer xenografts and cell lines.
    Hermans KG; van Alewijk DC; Veltman JA; van Weerden W; van Kessel AG; Trapman J
    Genes Chromosomes Cancer; 2004 Mar; 39(3):171-84. PubMed ID: 14732919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mapping of regions of physical deletion on chromosome 16q in prostate cancer cells by fluorescence in situ hybridization (FISH).
    Cher ML; Ito T; Weidner N; Carroll PR; Jensen RH
    J Urol; 1995 Jan; 153(1):249-54. PubMed ID: 7966782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneously detection of genomic and expression alterations in prostate cancer using cDNA microarray.
    Jiang M; Li M; Fu X; Huang Y; Qian H; Sun R; Mao Y; Xie Y; Li Y
    Prostate; 2008 Oct; 68(14):1496-509. PubMed ID: 18366025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LSAMP, a novel candidate tumor suppressor gene in human osteosarcomas, identified by array comparative genomic hybridization.
    Kresse SH; Ohnstad HO; Paulsen EB; Bjerkehagen B; Szuhai K; Serra M; Schaefer KL; Myklebost O; Meza-Zepeda LA
    Genes Chromosomes Cancer; 2009 Aug; 48(8):679-93. PubMed ID: 19441093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a novel homozygous deletion region at 6q23.1 in medulloblastomas using high-resolution array comparative genomic hybridization analysis.
    Hui AB; Takano H; Lo KW; Kuo WL; Lam CN; Tong CY; Chang Q; Gray JW; Ng HK
    Clin Cancer Res; 2005 Jul; 11(13):4707-16. PubMed ID: 16000565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disclosure of candidate genes in acute myeloid leukemia with complex karyotypes using microarray-based molecular characterization.
    Rücker FG; Bullinger L; Schwaenen C; Lipka DB; Wessendorf S; Fröhling S; Bentz M; Miller S; Scholl C; Schlenk RF; Radlwimmer B; Kestler HA; Pollack JR; Lichter P; Döhner K; Döhner H
    J Clin Oncol; 2006 Aug; 24(24):3887-94. PubMed ID: 16864856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genomic analysis of prostate carcinoma specimens obtained via ultrasound-guided needle biopsy may be of use in preoperative decision-making.
    Teixeira MR; Ribeiro FR; Eknaes M; Waehre H; Stenwig AE; Giercksky KE; Heim S; Lothe RA
    Cancer; 2004 Oct; 101(8):1786-93. PubMed ID: 15386312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allelic loss at 16q23.2 is associated with good prognosis in high grade prostate cancer.
    Fromont G; Valeri A; Cher M; Pontes JE; Vallancien G; Validire P; Latil A; Cussenot O
    Prostate; 2005 Dec; 65(4):341-6. PubMed ID: 16015610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Minimum altered regions in early prostate cancer progression identified by high resolution whole genome tiling path BAC array comparative hybridization.
    Watson SK; Woolcock BW; Fee JN; Bainbridge TC; Webber D; Kinahan TJ; Lam WL; Vielkind JR
    Prostate; 2009 Jun; 69(9):961-75. PubMed ID: 19267368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and fine mapping of a region showing a high frequency of allelic imbalance on chromosome 16q23.2 that corresponds to a prostate cancer susceptibility locus.
    Paris PL; Witte JS; Kupelian PA; Levin H; Klein EA; Catalona WJ; Casey G
    Cancer Res; 2000 Jul; 60(13):3645-9. PubMed ID: 10910080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human chromosome 16 suppresses metastasis but not tumorigenesis in rat prostatic tumor cells.
    Mashimo T; Watabe M; Cuthbert AP; Newbold RF; Rinker-Schaeffer CW; Helfer E; Watabe K
    Cancer Res; 1998 Oct; 58(20):4572-6. PubMed ID: 9788603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Array-comparative genomic hybridization of central chondrosarcoma: identification of ribosomal protein S6 and cyclin-dependent kinase 4 as candidate target genes for genomic aberrations.
    Rozeman LB; Szuhai K; Schrage YM; Rosenberg C; Tanke HJ; Taminiau AH; Cleton-Jansen AM; Bovée JV; Hogendoorn PC
    Cancer; 2006 Jul; 107(2):380-8. PubMed ID: 16779802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined array-comparative genomic hybridization and single-nucleotide polymorphism-loss of heterozygosity analysis reveals complex genetic alterations in cervical cancer.
    Kloth JN; Oosting J; van Wezel T; Szuhai K; Knijnenburg J; Gorter A; Kenter GG; Fleuren GJ; Jordanova ES
    BMC Genomics; 2007 Feb; 8():53. PubMed ID: 17311676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA copy number alterations in prostate cancers: a combined analysis of published CGH studies.
    Sun J; Liu W; Adams TS; Sun J; Li X; Turner AR; Chang B; Kim JW; Zheng SL; Isaacs WB; Xu J
    Prostate; 2007 May; 67(7):692-700. PubMed ID: 17342750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular analysis of multifocal prostate cancer by comparative genomic hybridization.
    Kobayashi M; Ishida H; Shindo T; Niwa S; Kino M; Kawamura K; Kamiya N; Imamoto T; Suzuki H; Hirokawa Y; Shiraishi T; Tanizawa T; Nakatani Y; Ichikawa T
    Prostate; 2008 Dec; 68(16):1715-24. PubMed ID: 18781578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrative analysis of genomic aberrations associated with prostate cancer progression.
    Kim JH; Dhanasekaran SM; Mehra R; Tomlins SA; Gu W; Yu J; Kumar-Sinha C; Cao X; Dash A; Wang L; Ghosh D; Shedden K; Montie JE; Rubin MA; Pienta KJ; Shah RB; Chinnaiyan AM
    Cancer Res; 2007 Sep; 67(17):8229-39. PubMed ID: 17804737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of recurrent copy number loss at Yp11.2 involving TSPY gene cluster in prostate cancer using array-based comparative genomic hybridization.
    Vijayakumar S; Hall DC; Reveles XT; Troyer DA; Thompson IM; Garcia D; Xiang R; Leach RJ; Johnson-Pais TL; Naylor SL
    Cancer Res; 2006 Apr; 66(8):4055-64. PubMed ID: 16618725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.